BioStack raises $9.5 million seed round led by Peak XV
BioStack, a healthcare technology startup, has raised $9.5 million in a seed round led by Peak XV and Afore Capital. DCVC, Emerson Collective, SV Angel, Verdict Capital, Streamlined Ventures, and Y Combinator also participated.
The company said the fresh capital will support international expansion, technology development and the growth of its engineering and research teams.
BioStack, co-founded by Sanat Mishra and Parth Patwa, connects fragmented clinical information across hospitals and healthcare systems to build longitudinal patient records.
Those records combine clinical notes, lab results, medical imaging, medications, treatment histories, and patient outcomes, all drawn from de-identified data.
From that data, the company builds proprietary datasets for medical research, drug development, and the training and evaluation of healthcare AI models.
Newsletter
The corridor, every morning.
Funding rounds and cross-border capital moves, one email, five minutes.
Its platform is designed for uses such as disease modelling, biomarker discovery, patient stratification, and treatment response analysis.
BioStack is building a data infrastructure network across the US, India, Brazil, and Argentina, with access to more than 100 million de-identified patient records.
It claims to have aggregated several hundred thousand X-rays, MRI and CT scans, along with millions of telehealth audio transcripts and other clinical records.
Its platform also includes workflows tailored to individual healthcare providers and their data privacy protocols.
In India, the company is also helping connect cancer patients with an investigational cancer vaccine programme.
More in Funding
